Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite

Clinical trial NCT04996264 · COMPLETED

Trial details

NCT number: NCT04996264
Sponsor: Ophirex, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Snakebites Envenoming Envenoming, Snake Envenomation, Snake

Start date: 2021-08-15
Primary completion: 2023-06-07
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.